Kidney Stones Management Market Size By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine) By Diagnostics (Abdominal X-ray, Computed Tomography Scan, Ultrasound, Abdominal MRI, Intravenous Pyleography, Others) By Treatment (Extracorporeal shock wave lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy, Others) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE) Application Potential, Competitive Market Share & Forecast, 2018 – 2024
Published Date: May 2018 | 150 Pages | Report ID: GMI2603 Report Format: PDF
Kidney Stones Management Market size was over USD 1,649 Million in 2017, with growth forecast over 4.1% CAGR from 2018 to 2024.
U.S. Kidney Stones Management Market Size, by Treatment, 2013-2024 (USD Million)
Get more details on this report by requesting a free sample copy
Kidney stones management market has achieved a stable growth rate over the past few years, while this trend is set to continue further owing to increasing prevalence and recurrence rate of kidney stones globally. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than one million kidney stone cases are registered every year in the U.S. of which around 3 lac patients are admitted to emergency department due to kidney stone complications.
The latest trends in kidney stones management industry are extensively driven by technological advancements in the field of ESWL and ureteroscopy. The advent of flexible ureteroscopes is one of the most significant advances that have revolutionized the treatment of intrarenal and proximal kidney stones. The improvement in image quality due to use of high definition cameras and digital imaging has further led to better visualization and more accurate treatment.
Treatment of kidney stones using minimally invasive procedures such as laparoscopic, robotic, percutaneous and ureteroscopic surgeries has gained popularity over fast few years. Various hospitals are significantly investing in employing minimally invasive surgical procedures for kidney-related diseases such as tumours, kidney stones, and removal of poorly functioning kidneys. A large patient population opting for minimally invasive surgeries is likely to boost the market.
Remarkable increase in number of kidney-related diseases and other urological conditions affecting population has generated need to create awareness regarding overall kidney health, and timely screening and diagnosis of disease to receive appropriate treatment. Various organizations and companies across the world are working towards raising awareness for receiving affordable and equitable access to screening, diagnosis and treatment options.
World Kidney Day is one such global awareness campaign aimed at raising awareness regarding kidney health and related diseases. It is joint initiative started in 2006 undertaken by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF). This campaign encourages screening of patients who pose high risk for kidney related diseases. Rising awareness regarding overall kidney health should further spearhead the kidney stones management market space.
However, issues such as lack of treatment awareness in certain countries, and presence of surgical procedures and usage of drugs as an alternative therapy to address medical condition may pull down the growth of kidney stones management market. Apart from this, potential long-term adverse effects of one of the most commonly used and effective treatment for kidney stones, lithotripsy may impede market growth.
Kidney Stones Management Market, By Type
Calcium oxalate ruled the overall kidney stones management market with a share of over 75% in 2017. Majority of kidney stones are composed of calcium oxalate and calcium phosphate followed by struvite, uric acid and cysteine.
Consumption of more than recommended amount of oxalate rich food coupled with less intake of fluids leads to this type of stone formation. The trend is set to continue and estimated to grow at a CAGR of over 4.2% through 2018-2024.
Kidney Stones Management Market, By Diagnostics
In 2017, computed tomography (CT) scan covered around 30% of the market share and is set to generate considerable revenue over the coming seven years, primarily driven by the widespread adoption of this technology as a gold standard for diagnosing kidney stones.
Ultrasound has also evolved as an equally accurate and reliable technology for diagnosing kidney stones. Moreover, due to low radiation exposure and cost effectiveness, the technology is set to achieve higher penetration in the years to come. Ultrasound for kidney stones management market is slated to reach over USD 550 million by 2024.
Kidney Stones Management Market, By Treatment
Extracorporeal shock wave lithotripsy (ESWL) dominated the overall kidney stones management market in 2017, having held more than 58% of the total revenue share, successively followed by ureteroscopy and percutaneous nephrolithotomy respectively. The ESWL target market size is anticipated to reach over USD 970 million in 2017.
The largest share of the segment is attributed to non-invasive nature of shock waves procedure for treating kidney stones. Furthermore, these devices have been reduced in size occupying less space with more efficient targeting systems such as electromagnetic and piezoelectric sources to deliver accurate energy to stones.
Ureteroscopy is certain to emerge as remarkably popular technology in the coming years registering lucrative CAGR of 5.1% during forecast period. The advent of smaller and flexible ureteroscopes, higher-definition cameras, and variety of instrumentation and accessories should drive the business growth.
Kidney Stones Management Market, By Region
U.S. garnered the largest regional share in the North America kidney stones management market garnering a revenue share of more than 90% in 2017. Considering the rising prevalence of kidney stones and recurrence rate in the region, use of advanced treatment options, and adoption of minimally invasive surgical procedures, U.S. is set to accumulate major chunk of kidney stones management market in the coming years.
Given that technology plays a vital role in the development of this business space, developed countries such as Germany and UK claim to contribute more than 53% revenue share towards Europe market in 2017. Moreover, high awareness regarding overall kidney health in this region has led to more number of people undergoing screening for kidney diseases resulting into rise in diagnosis rate.
Emerging countries of China and India have arisen to be potential business ground for kidney stone management market in the coming years. The increase in geriatric population and rising prevalence of diabetes and hypertension in these regions is set to generate potential patient pool of kidney stones in the coming years. China kidney stones management industry will record a CAGR of 7.4% over 2018–2024.
Competitive Market Share
Olympus, C. R. Bard, Richard Wolf GmbH, Boston Scientific, Coloplast, and Cook Medical are the major players in kidney stones management market. Other noteworthy players include Dornier Medtech, Karl Storz, Allengers Medical Systems, DireX, Elmed Medical Systems and Medispec among others.
Mergers and acquisition as well as launch of technologically advanced products will continue to be a major business strategy adopted by the players operating in kidney stones management business sphere. The firms strive to capture maximum market share by employing various growth strategies.
Kidney Stones Management Industry Background
Get more details on this report by requesting a free sample copy
Kidney stones management industry witnesses strict regulatory structure. These devices are classified as Class II i.e. moderate-risk by the U.S. FDA. Thus, FDA clearance through the Premarket Notification [510(k)] process is required for their marketing. Lithotripters are classified as Class II medical devices and need to comply general controls and special controls standards in order to be sold or marketed. Since the general controls do not provide sufficient and reasonable assurance of the safety and effectiveness of the device, special controls are established for these devices which include performance standards, post market surveillance, patient registries, special labelling requirements, and premarket data requirements.
What Information does this report contain?
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team